Literature DB >> 32750373

Cardiac Rehabilitation for Patients Treated for Atrial Fibrillation With Ablation Has Long-Term Effects: 12-and 24-Month Follow-up Results From the Randomized CopenHeartRFA Trial.

Signe Stelling Risom1, Ann-Dorthe Zwisler2, Kirstine Lærum Sibilitz3, Trine Bernholdt Rasmussen4, Rod Stephen Taylor5, Lau Caspar Thygesen6, Trine Stougaard Madsen7, Jesper Hastrup Svendsen8, Selina Kikkenborg Berg9.   

Abstract

OBJECTIVE: To assess outcomes at 12 and 24 months after participation in a multidisciplinary cardiac rehabilitation program plus usual care compared with usual care alone for patients treated for atrial fibrillation with catheter ablation.
DESIGN: Long-term follow-up on the randomized CopenHeartRFA trial.
SETTING: Patients were enrolled and outcome assessed at the hospital and the intervention were carried out at the hospital or at local rehabilitation centers. PARTICIPANTS: Patients (N=210) treated for atrial fibrillation with catheter ablation included in the CopenHeartRFA trial.
INTERVENTIONS: A 6-month cardiac rehabilitation program consisting of physical exercise and psychoeducational consultations plus usual care or usual care alone. MAIN OUTCOME MEASURES: Physical capacity was measured by peak oxygen uptake (Vo2peak) at 12 months, and patient-reported outcomes on perceived health, anxiety, and depression were collected by validated questionnaires at 12 and 24 months. Information on hospital admissions and mortality was collected through national registers up to 24 months.
RESULTS: Mean Vo2peak was higher at 12 months in the cardiac rehabilitation group (cardiac rehabilitation group: 25.82 mL/kg/min vs usual care group, 22.43 mL/kg/min, P=.003). A lower proportion of patients had high levels of anxiety at 24 months in the cardiac rehabilitation group compared to usual care (12% vs 24%, P=.004). There was no difference in mortality or hospital admissions at 24 months between groups.
CONCLUSIONS: This long-term follow-up of a comprehensive multidisciplinary cardiac rehabilitation program for patients treated for atrial fibrillation with catheter ablation found sustained improvements with respect to physical capacity and anxiety compared to usual care but no difference on mortality or hospital admission.
Copyright © 2020 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Cardiac rehabilitation; Patient readmission; Patient reported outcome measures; Quality of life; Rehabilitation

Year:  2020        PMID: 32750373     DOI: 10.1016/j.apmr.2020.06.026

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  5 in total

1.  Cardiac rehabilitation for older adults: current evidence and future potential.

Authors:  Maha A Alfaraidhy; Claire Regan; Daniel E Forman
Journal:  Expert Rev Cardiovasc Ther       Date:  2022-02-13

Review 2.  Lifestyle Modification and Atrial Fibrillation: Critical Care for Successful Ablation.

Authors:  John L Fitzgerald; Melissa E Middeldorp; Celine Gallagher; Prashanthan Sanders
Journal:  J Clin Med       Date:  2022-05-09       Impact factor: 4.964

Review 3.  Atrial Fibrillation Specific Exercise Rehabilitation: Are We There Yet?

Authors:  Benjamin J R Buckley; Signe S Risom; Maxime Boidin; Gregory Y H Lip; Dick H J Thijssen
Journal:  J Pers Med       Date:  2022-04-10

4.  Effect of an Exercise and Nutrition Program on Quality of Life in Patients With Atrial Fibrillation: The Atrial Fibrillation Lifestyle Project (ALP).

Authors:  Jesse Bittman; Cynthia J Thomson; Lloyd A Lyall; Stephanie L Alexis; Eric T Lyall; Sebastian L Cannatella; Mahasti Ebtia; Alexander Fritz; Benjamin K Freedman; Nooshin Alizadeh-Pasdar; Joan M LeDrew; Teddi L Orenstein Lyall
Journal:  CJC Open       Date:  2022-04-27

5.  Research Priorities in the Secondary Prevention of Atrial Fibrillation: A National Heart, Lung, and Blood Institute Virtual Workshop Report.

Authors:  Emelia J Benjamin; Sana M Al-Khatib; Patrice Desvigne-Nickens; Alvaro Alonso; Luc Djoussé; Daniel E Forman; Anne M Gillis; Jeroen M L Hendriks; Mellanie True Hills; Paulus Kirchhof; Mark S Link; Gregory M Marcus; Reena Mehra; Katherine T Murray; Ratika Parkash; Ileana L Piña; Susan Redline; Michiel Rienstra; Prashanthan Sanders; Virend K Somers; David R Van Wagoner; Paul J Wang; Lawton S Cooper; Alan S Go
Journal:  J Am Heart Assoc       Date:  2021-08-05       Impact factor: 6.106

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.